White matter changes in schizophrenia: evidence for myelin-related dysfunction.
about
Neuroinflammation and psychiatric illnessRecent advances in the genetics of schizophreniaOligodendrocyte genes, white matter tract integrity, and cognition in schizophreniaDiffusion abnormalities in adolescents and young adults with a history of heavy cannabis useCorpus callosum abnormalities and their association with psychotic symptoms in patients with schizophreniaThe involvement of Reelin in neurodevelopmental disorders.Prenatal nutritional deficiency and risk of adult schizophreniaFronto-temporal disconnectivity in schizotypal personality disorder: a diffusion tensor imaging studyThe neurodevelopmental hypothesis of schizophrenia, revisitedConvergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophreniaGenetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophreniaEmerging functions of the Quaking RNA-binding proteins and link to human diseasesSynchrony in schizophrenia: a window into circuit-level pathophysiologyProfile of minocycline and its potential in the treatment of schizophreniaA putative functional role for oligodendrocytes in mood regulationPhenotypic characterization of transgenic mice overexpressing neuregulin-1Single-neuron and genetic correlates of autistic behavior in macaque.From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids MetabolismIloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapyAn association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophreniaSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergenceTargeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia.Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotectionQuetiapine Ameliorates Schizophrenia-Like Behaviors and Protects Myelin Integrity in Cuprizone Intoxicated Mice: The Involvement of Notch Signaling Pathway.Auditory verbal hallucinations and the interhemispheric auditory pathway in chronic schizophrenia.Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlatesPrenatal infection and schizophrenia: a review of epidemiologic and translational studies.The environment and susceptibility to schizophrenia.Loss of function studies in mice and genetic association link receptor protein tyrosine phosphatase α to schizophrenia.Increased expression of receptor phosphotyrosine phosphatase-β/ζ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes.Evolution of increased glia-neuron ratios in the human frontal cortex.A classification of sociomedical health indicators: perspectives for health administrators and health planners.Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model.Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics.Three-dimensional brain growth abnormalities in childhood-onset schizophrenia visualized by using tensor-based morphometryModeling GABA alterations in schizophrenia: a link between impaired inhibition and altered gamma and beta range auditory entrainmentDownregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats.Nogo Receptor 1 (RTN4R) as a candidate gene for schizophrenia: analysis using human and mouse genetic approaches.Searching for neuropathology: gliosis in schizophrenia.Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression
P2860
Q21245244-4A1FFF45-B7EB-4735-BCC3-540607254D3FQ22242872-3137C5B2-6C1A-466A-A657-A540592EB219Q24289198-DDF50FD5-D030-4A15-BBA5-D34A710FE0C3Q24608718-AC1A4C8F-504F-403A-BF6A-E07955D52866Q24616310-1FDCD4AF-1A77-403E-B2BD-32E7D32EA5CFQ24632484-364965E6-F7F0-4A3B-ACA6-EAF9B3058088Q24643484-76F98A49-DA6D-49BB-AE49-06C1BA025A4BQ24648380-31D00E38-E5B4-47D6-B0DC-C6954F78C59DQ24658343-C591AEFD-4E08-4E1F-94B4-4560026B62A9Q24670103-6388B903-60A6-4432-8C28-CA2D3C99EAF7Q24682717-14F65B96-9777-46CD-825C-08DEA0BCB3D6Q26753819-64C878D9-56EB-4971-B72F-005A419A089FQ26823018-18469D60-814F-4D07-849D-9CCDCDF57BA8Q26864400-FDD5B8DF-A2AC-4F5C-883C-15185B086860Q26995174-CD09A37D-0011-498E-9D50-9E54B5A9F4F7Q27316077-40FB16E5-C3E0-4CA4-AA6E-C4F6BBB9E7E0Q27333227-17A16886-1930-4AC6-AF45-19D4D14DEE82Q28067617-C581435E-7B79-4693-A514-694D5DDFA4E1Q28078158-D15175E8-1B27-46F9-9F17-CA2D96BDF2C0Q28250481-62E3956F-FB7E-41C3-98CA-5C7FFF80D921Q29618819-668AD51D-52CF-4A46-A76C-B4EA2C8892E1Q30380519-1702ED1B-6399-4A1C-9BD8-02F6207807E0Q30386608-0571B290-8846-48D4-9C79-5D781266D756Q30389701-5E222CB5-9EF4-4FF9-A1B8-E7B8CFEED479Q30394550-DE320746-D75F-4350-B3E1-AA420E4E6451Q30450267-C48A5EB2-36CF-479F-BAE1-0D7AE13EB1EBQ30454666-B03A9C74-2C59-4444-BCC9-23F8213FB45EQ30459929-BF811F9C-A0D6-4006-9061-D1238A3279EFQ30462812-93633148-EAB3-4F8A-90EE-6CCDEE21B0A3Q30468818-3310A486-8C52-4380-81C6-234765FA8293Q30477953-E9A03301-E7C7-4012-BD2E-3FDEBCF3A7D5Q30478069-793A1D57-5DEC-4784-93E2-65D2427100FEQ30479725-AE71A472-52F2-4BA3-966A-0F42C8F07296Q30482602-3C2A6D19-0F9E-4AB6-A628-94ACF236F4FEQ30484045-7532B3B0-910C-44FE-9020-8D2B799BD28CQ30489759-CC8B37FF-A17B-45A7-9186-E864D5F52761Q30491249-6BB596DC-186E-4084-ADA7-F22AA33B710BQ30499718-3A6D63FA-C221-4877-9418-59F2F3A9A752Q30537360-0B6DB89E-B28A-4AEF-A7E9-FBD7AA173141Q30539567-5033F059-3529-4E3B-AB5F-AEB04124C866
P2860
White matter changes in schizophrenia: evidence for myelin-related dysfunction.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
White matter changes in schizophrenia: evidence for myelin-related dysfunction.
@ast
White matter changes in schizophrenia: evidence for myelin-related dysfunction.
@en
type
label
White matter changes in schizophrenia: evidence for myelin-related dysfunction.
@ast
White matter changes in schizophrenia: evidence for myelin-related dysfunction.
@en
prefLabel
White matter changes in schizophrenia: evidence for myelin-related dysfunction.
@ast
White matter changes in schizophrenia: evidence for myelin-related dysfunction.
@en
P2093
P50
P1433
P1476
White matter changes in schizophrenia: evidence for myelin-related dysfunction.
@en
P2093
Daniel G Stewart
Joseph I Friedman
Kenneth L Davis
Monte Buchsbaum
Patrick R Hof
P304
P356
10.1001/ARCHPSYC.60.5.443
P407
P577
2003-05-01T00:00:00Z